![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, July 20, 2023 12:51:23 PM
“It’s apparent with the recent developments of the bucillamine trial, it is proven that bucillamine is a powerful drug for luring people into the idea that it might be effective against anything to do with breathing. Clinical trials have proven that if you say “it looks as if bucillamine ”or “there might be evidence that bucillamine…” it is a powerful tool for market manipulation. The ability of Bucillamine (alias name of a poster) to put out countless Press Releases, indicates that bucillamine is a powerful tool in the epidemic of ‘pump and dump’ stocks. Bucillamine has proven to be a powerful IP for its CEO and board members to create unlimited hopium for investors. And when 2.0 is added to bucillamine it appears bucillamine can be 2.0 times as effective for bringing in new investors and will extend the life of bucillamine for another year. Who would have thought? Oh… yeah… MF.”
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM